Anti-HIV activity of new substituted 1,3,4-oxadiazole derivatives and their acyclic nucleoside analogues

Zeitschrift fur Naturforschung - Section C Journal of Biosciences

Volumn 64, Issue 11-12, 2010, Pages 773-778

  El Sayed, Wael A ^a   El Essawy, Farag A ^b   Ali, Omar M ^b   Nasr, Barsis S ^b   Abdalla, Mohamed M ^c   Abdel Rahman, Adel A H ^b  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b Menoufia University   (Egypt)

^c Univet Pharmaceutical Co   (Egypt)

Author keywords

1,3,4 oxadiazoles; Acyclic nucleosides; Antiviral activity; Sugar hydrazones

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 74049108213     PISSN: 09395075     EISSN: None     Source Type: Journal    
DOI: 10.1515/znc-2009-11-1203     Document Type: Article

References (33)

1. Abdel-Aal M. T., El-Sayed W. A., and El-Ashry E. S. H. (2006), Synthesis and antiviral evaluation of some sugar arylglycinoylhydrazones and their oxadiazoline derivatives. Arch. Pharm. Chem. Life. Sci. 339, 356-663.
2. Abdel-Aal M. T., El-Sayed W. A., El-Kosy S. M., and El-Ashry E. S. H. (2008), Synthesis and antiviral evaluation of novel 5-(N-aryl-aminomethyl-1,3,4-oxadiazol-2-yl)hydrazines and their sugars, 1,2,4-triazoles, tetrazoles and pyrazolyl derivatives. Arch. Pharm. Chem. Life Sci. 341, 307-313.
3. Ali O. M., Amer H. H., and Abdel-Rahman A. A. H. (2007), Synthesis and antiviral evaluation of sugar uracil-1-ylmethylhydrazones and their oxadiazoline derivatives. Synthesis 18, 2823-2828.
4. Ates O., Kocabalkanli A., Sanis G. O., Ekinci A. C., and Vidin A. (1997), Synthesis and antibacte rial activity of 5-aryl-2-((α-chloro-α-phenylacetyl-α-bromopropionyl)amino)-1,3,4-oxadiazoles and 2-((5-aryl-1,3,4-oxadiazol-2-yl)imino)-5-phenyl-methyl-4-thiazolidinones. Drug Res. 47, 1134-1140.
5. Bosworth N. and Towers P. (1989), Scintillation proximity assay. Nature 341, 167-168.
6. Buckheit R. W., Jr., Kinjerski T. L., Fliakas-Boltz V. J., Russell D., Stup T. L., Pallansch L. A., Brouwer W. G., Dao D. C., Harrison W. A., Schultz R. J., Bader J. P., and Yang S. S. (1995), Structure-activity and cross-resistance evaluations of a series of human immunodeficiency virus type 1-specific compounds related to oxathione carboxanilide. Antimicrob. Agents Chemother. 39, 2718-2727.
7. Byrnes V. W., Sardana V. V., Schleif W. A., Condra J. H., Waterbury J. A., Wolfgang J. A., Long W. J., Schneider C. L., Schlabach A. J., and Wolanski B. S. (1993), Comprehensive mutant enzyme and viral variant assessment of human immunodeficiency virus type 1 reverse transcriptase resistance to nonnucleoside inhibitors. Antimicrob. Agents Chemother. 37, 1576-1579.
8. Chu C. K. and Cutler S. J. (1986), Chemistry and antiviral activities of acyclonucleosides. J. Heterocycl. Chem. 23, 289-319.
9. El Ashry E. S. H. and El Kilany Y. (1996), Acyclonucleosides: part 1. Seco-nucleosides. Adv. Heterocycl. Chem. 67, 391-438.
10. El Ashry E. S. H. and El Kilany Y. (1997), Acyclonucleosides: part 2. Diseco-nucleosides. Adv. Heterocycl. Chem. 68, 1-88.
11. El Ashry E. S. H. and El Kilany Y. (1998), Acyclonucleosides: part 3. Tri-, tetra-, and pentaseco-nucleosides. Adv. Heterocycl. Chem. 69, 129-215.
12. El-Azzouny A. A., Maklad Y. A., Bartsch H., Zaghary W. A., Ibrahim W. M., and Mohamed M. S. (2003), Synthesis and pharmacological evaluation of fenamate analogues: 1,3,4-Oxadiazol-2-ones and 1,3,4-oxadiazole-2-thiones. Sci. Pharm. 71, 331-336.
13. El-Emam A. A., Al-Deep A. O., Al-Omar M., and Lehmann J. (2004), Synthesis, antimicrobial, and anti-HIV-1 activity of certain 5-(1-adamantyl)-2-substituted thio-1,3,4-oxadiazoles and 5-(1-adamantyl)-3-substituted aminomethyl-1,3,4-oxadiazoline-2-thiones. Bioorg. Med. Chem. 12, 5107-5113.
14. El-Essawy F. A., El-Sayed W. A., El-Kafrawy S. A., Morshedy A. S., and Abdel-Rahman A. H. (2008), Anti-hepatitis B virus activity of new 1,2,4-triazol-2-yl- and 1,3,4-oxadiazol-2-yl-2-pyridinone derivatives. Z. Naturforsch. 63c, 667-772.
15. El-Sayed W. A., Fathi N. M., Gad W. A., and El-Ashry E. S. H. (2008), Synthesis and antiviral evaluation of some 5-N-arylaminomethyl-2-glycosylsulphanyl-1,3,4-oxadiazoles and their analogues against hepatitis A and herpes simplex viruses. J. Carbohydr. Chem. 27, 357-372.
16. Franchetti P., Cappellacci L., AbuSheikha G., Jayaram H. N., Gurudutt V. V., Sint T., Schneider B. P., Jones W. D., Goldstein B. M., Perra G., DeMontis A., Loi A. G., LaColla P., and Grifantini M. (1997), Synthesis, structure, and antiproliferative activity of selenophenfurin, an inosine 5'-monophosphate dehydrogenase inhibitor analogue of selenazofurin. J. Med. Chem. 40, 1731-1737.
17. Guo W. and Romano J. (2007), A generalized SidakHolm procedure and control of generalized error rates under independence. Stat. Appl. Genet. Mol. Biol. 6, 3-4.
18. Hammerschmidt F., Peric B., and Ohler E. (1997), Synthesis of D-apio-β-D-furanosyl maleimide, an analogue of showdomycin with transposed hydroxyme- thyl group. Monatsh. Chem. 128, 183-190.
19. Holy A. (1987), Phosphonylmethyl analogs of nucleotides and their derivatives: Chemistry and biology. Nucleosides Nucleotides 6, 147-155.
20. Larson A., Alenius S., Johnsson N. G., and Oberg B. (1983), Antiherpetic activity and mechanism of action of 9-(4-hydroxybutyl)guanine. Antiviral Res. 3, 77-86.
21. Li X. Z. Z., Wang Y., Chen W., Huang Q., Liu C., and Song G. (2003), Syntheses and insecticidal activities of novel 2,5-disubstituted 1,3,4-oxadiazoles. J. Fluor. Chem. 123, 163-169.
22. Liszkiewicz H., Kowalska M. W., Wietrzyk J., and Opolski A. (2003), Synthesis and anti-proliferative activity in vitro of new 5-(2-amino-3-pyridyl)-2-thioxo-3H-1,3,4-oxadiazole derivatives. Ind. J. Chem. Sec. B-Org. Chem. Int. Med. Chem. 42, 2846-2852.
23. Loetchutinat C., Chau F., and Mankhetkorn S. (2003), Synthesis and evaluation of 5-aryl-3-(4-hydroxyphenyl)-1,3,4-oxadiazole-2-(3H)-thiones as P-glycoprotein inhibitors. Chem. Pharm. Bull. 51, 728-734.
24. Markar G. M. and Keseru G. M. (1997), On the conformation of tiazofurin analogues. J. Med. Chem. 40, 4154-4159.
25. Mhasalkar M. Y., Shah M. H., Pilankar P. D., Nikan S. T., Anantanarayan K. G., and Deliwala C. V. (1971), Synthesis and hypoglycemic activity of 3-aryl (or pyridyl)-5-alkyl (or aryl) amino-1,3,4-thiadiazoles and some sulfonylurea derivatives of 4H-1,2,4-triazoles. J. Med. Chem. 14, 1000-1003.
26. Palaska E., Sahin G., Kelicen P., Durlu N. T., and Altinok G. (2002), Synthesis and anti-inflammatory activity of 1-acylthiosemicarbazides, 1,3,4-oxadiazoles, 1,3,4-thiadiazoles and 1,2,4-triazole-3-thiones. Farmaco 57, 101-107.
27. Rahman A. and Farghaly A. R. (2004), Synthesis reactions and antimicrobial activity of some new indolyl-1,3,4-oxadiazole, triazole and pyrazole derivatives. J. Chin. Chem. Soc. 51, 147-156.
28. Remy R. J. and Secrist J. A. (1985), Acyclic nucleosides other than acyclovir as potential antiviral agents. Nucleosides Nucleotides 4, 411-427.
29. Somogyi L. (1977), 1,3,4-Oxadiazolines via acetylation of D-galactose acylhydrazones. Carbohydr. Res. 54, C14-C16.
30. Somogyi L. (1978), Synthesis of L-3-(3-deoxy-1,2:5,6-diO-isopropylidene-α-D-allofuranos-3-yl)alanine. Carbohydr. Res. 64, 289-292.
31. Zareen A., Maimoona R., Choudhary M. I., Supino Khan R., Khalid M., and Atta-ur-Rahman (2004), Kinetics of novel competitive inhibitors of urease enzymes by a focused library of oxadiazoles/thiadiazoles and triazoles. Biochem. Biophys. Res. Commun. 319, 1053-1063.
32. Zarling J. M., Moran P. A., Haffar O., Diegel M., Myers D. E., Kuelbeck V., Ledbetter J. A., and Uckun F. M. (1991), Inhibition of HIV-1 replication in seropositive patients CD41 T-cells by pokeweed antiviral protein-monoclonal antibody conjugates. Int. J. Immunopharmacol. 13, 63-68.
33. Zou X., Zhang Z., and Jin G. J. (2002), Synthesis and biological activity of 1,3,4-oxadiazole-substituted pyridazinones. J. Chem. Res. (S), 228-230.